1,223
Participants
Start Date
June 21, 2021
Primary Completion Date
December 7, 2023
Study Completion Date
December 7, 2023
Observational, prospective, follow-up of the recipients of CoronaVac (inactivated), Pfizer-Biontech (mRNA) vaccines
Based on the Turkish Ministry of Health regulations, any research protocol involving use of any drug/vaccine needs to be presented in a clinical trial format, and is presented to the clinical research ethical boards accordingly. Otherwise, the study has no intervention (to the exposure status) involved. Selection, administration, number of doses applied and the period between vaccine doses are beyond the capacity the study team.
Hacettepe University, Sıhhiye Campus, Ankara
Hacettepe University
OTHER